Meta-analysis of microsatellite instability in relation to clinicopathological characteristics and overall survival in gastric cancer
Background Several associations between microsatellite instability (MSI) and other
clinicopathological factors have been reported in gastric cancer, but the results have been …
clinicopathological factors have been reported in gastric cancer, but the results have been …
Lauren classification and individualized chemotherapy in gastric cancer
J Ma, H Shen, L Kapesa, S Zeng - Oncology letters, 2016 - spandidos-publications.com
Gastric cancer is one of the most common malignancies worldwide. During the last 50 years,
the histological classification of gastric carcinoma has been largely based on Lauren's …
the histological classification of gastric carcinoma has been largely based on Lauren's …
From tumor immunology to immunotherapy in gastric and esophageal cancer
D Vrána, M Matzenauer, Č Neoral, R Aujeský… - International journal of …, 2018 - mdpi.com
Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately,
radiotherapy, chemotherapy, and targeted therapy have made only limited progress in …
radiotherapy, chemotherapy, and targeted therapy have made only limited progress in …
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Y Zhang, Y Yang, Y Chen, W Lin, X Chen, J Liu… - Frontiers in …, 2022 - frontiersin.org
Gastric cancer (GC) is one of the main causes of cancer incidence rate and mortality
worldwide. As the main breakthrough direction, the application of immune checkpoint …
worldwide. As the main breakthrough direction, the application of immune checkpoint …
Heterogeneity in gastric cancer: from pure morphology to molecular classifications
Gastric cancer (GC) represents a global health concern. Despite advances in prevention,
diagnosis, and therapy, GC is still the third leading cause of cancer mortality worldwide, with …
diagnosis, and therapy, GC is still the third leading cause of cancer mortality worldwide, with …
Elevated risk of prostate cancer among men with Lynch syndrome
VM Raymond, B Mukherjee, F Wang… - Journal of clinical …, 2013 - ascopubs.org
Purpose Prostate cancer has been described as a component tumor of Lynch syndrome
(LS), with tumors obtained from mutation carriers demonstrating the DNA mismatch repair …
(LS), with tumors obtained from mutation carriers demonstrating the DNA mismatch repair …
Diagnosis of Lynch syndrome and strategies to distinguish Lynch-related tumors from sporadic MSI/dMMR tumors
J Leclerc, C Vermaut, MP Buisine - Cancers, 2021 - mdpi.com
Simple Summary Microsatellite instability (MSI) is a hallmark of Lynch syndrome (LS)-related
tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are …
tumors but is not specific, as most of MSI/mismatch repair-deficient (dMMR) tumors are …
Clinicopathologic characteristics of microsatellite instable gastric carcinomas revisited: urgent need for standardization
M Mathiak, VS Warneke, HM Behrens… - Applied …, 2017 - journals.lww.com
Microsatellite instable gastric cancer (MSI-GC) is a specific molecular subtype of GC. We
studied the phenotypes, genotypes, and clinicopathologic characteristics of MSI-GC in a …
studied the phenotypes, genotypes, and clinicopathologic characteristics of MSI-GC in a …
The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: results from a large cohort with subgroup analyses
SY Kim, YY Choi, JY An, HB Shin, A Jo… - … Journal of Cancer, 2015 - Wiley Online Library
We previously reported that the prognosis of microsatellite instability high (MSI‐H) gastric
cancer is similar to that of MSI‐low/microsatellite stable (MSI‐L/MSS) gastric cancer. The …
cancer is similar to that of MSI‐low/microsatellite stable (MSI‐L/MSS) gastric cancer. The …
Influence of microRNAs and long non-coding RNAs in cancer chemoresistance
D Ayers, J Vandesompele - Genes, 2017 - mdpi.com
Innate and acquired chemoresistance exhibited by most tumours exposed to conventional
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …
chemotherapeutic agents account for the majority of relapse cases in cancer patients. Such …